Disc Medicine IRON
NASDAQ IRON
$79.23 -0.14 (-0.18%)
As of: Sep 4, 2026 · 3:59 PM EDT

Disc Medicine (IRON) Current Assets (2020 - 2026)

Disc Medicine (IRON) posted quarterly Current Assets of $732.8 million for Q2 2026, up 10.76% year-over-year from $661.6 million in Q2 2025, and down 1.97% quarter-over-quarter from $747.5 million in Q1 2026.

Analysis

Disc Medicine (IRON) Current Assets (2020 - 2026) Analysis & Trends

Disc Medicine (IRON) has reported Current Assets for 7 consecutive years, with $732.8 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Current Assets rose 10.76% year-over-year to $732.8 million; the TTM figure through Jun 2026 stood at $732.8 million (up 10.76% YoY), while the FY2025 annual figure was $803.9 million, up 62.86% from the prior year.
  • Current Assets fell to $732.8 million in Q2 2026 per IRON's latest filing, from $747.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $803.9 million in Q4 2025 and bottomed at $104.7 million in Q3 2022.
  • Historically, Current Assets has averaged $446.1 million across 5 years, with a median of $437.4 million in 2023.
  • Annual changes were most pronounced in 2022 — Current Assets plunged 34.22% — and 2023, when it soared 257.59%.
  • Disc Medicine's Current Assets stood at $198.5 million in 2022, then surged by 84.22% to $365.7 million in 2023, then soared by 34.99% to $493.6 million in 2024, then soared by 62.86% to $803.9 million in 2025, then decreased by 8.85% to $732.8 million in 2026.
  • Business Quant data shows IRON's Current Assets at $732.8 million in Q2 2026, $747.5 million in Q1 2026, and $803.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 12.54 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 18.45 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.07 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.82 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.03 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7.22 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.62 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.76 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.63 Bn
10 Disc Medicine 3.06 Bn 3.06 Bn - 732.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 732.76 Mn
Mar 31, 2026 747.46 Mn
Dec 31, 2025 803.90 Mn
Sep 30, 2025 627.17 Mn
Jun 30, 2025 661.59 Mn
Mar 31, 2025 705.60 Mn
Dec 31, 2024 493.62 Mn
Sep 30, 2024 493.15 Mn
Jun 30, 2024 508.24 Mn
Mar 31, 2024 351.95 Mn
Dec 31, 2023 365.66 Mn
Sep 30, 2023 374.26 Mn
Jun 30, 2023 381.73 Mn
Mar 31, 2023 242.14 Mn
Dec 31, 2022 198.49 Mn
Sep 30, 2022 104.66 Mn
Jun 30, 2022 113.13 Mn
Mar 31, 2022 124.07 Mn
Dec 31, 2021 90.48 Mn
Sep 30, 2021 154.80 Mn